Imaging [18F]AV-1451 and [18F]AV-45 in Acute and Chronic Traumatic Brain Injury

Trial Profile

Imaging [18F]AV-1451 and [18F]AV-45 in Acute and Chronic Traumatic Brain Injury

Phase of Trial: Phase IV

Latest Information Update: 20 Jul 2017

At a glance

  • Drugs Florbetapir F 18 (Primary) ; Flortaucipir F 18 (Primary)
  • Indications Brain injuries; Mild cognitive impairment
  • Focus Diagnostic use
  • Most Recent Events

    • 20 Jul 2017 Results (n=28) presented at the Alzheimer's Association International Conference 2017
    • 10 Jun 2017 Biomarkers information updated
    • 09 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top